HeMo ApS: Financial statements 2023
CVR: 36462558
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
HeMo ApS (CVR 36462558) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 480,105 and a net result of DKK -68,265 compared with DKK 156,699 the year before. That is a decrease of 45.7% compared with the year before. Equity in the 2023 report amounted to DKK 218,050. The solvency ratio was 44.8%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 480,105
- Profit/Loss
- DKK -68,265
- Equity
- DKK 218,050
- Total Assets
- DKK 487,034
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 480 t. | -68 t. | 218 t. | 1 |
| 2022 | - | 885 t. | 157 t. | 345 t. | 1 |
| 2021 | - | 921 t. | 312 t. | 57 t. | 1 |
| 2020 | - | 874 t. | -214 t. | -255 t. | 1 |
| 2019 | - | 829 t. | -435 t. | -41 t. | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
HeMo ApS has published its annual report for 2022. Gross profit came to DKK 884,702, and the net result was DKK 156,699.
About HeMo ApS
HeMo ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2014. The company is registered under the industry Investering for egen regning. The management consists of Henrik Mordhorst. The company is owned by Henrik Mordhorst. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 523,023 and a net result of DKK 10,715 compared with DKK 83,590 the year before. Equity in the 2025 report amounted to DKK 183,855.